Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07000851 · ClinicalTrials.gov registry record
Imaging Studies in Corticobasal Syndrome
A clinical trial of Corticobasal Degeneration and Corticobasal Syndrome, sponsored by Jennifer Whitwell.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT07000851: Recruiting study of Corticobasal Degeneration and Corticobasal Syndrome, sponsored by Jennifer Whitwell.
NCT07000851 is a study of Corticobasal Degeneration and Corticobasal Syndrome that is actively recruiting participants, run by Jennifer Whitwell. The registered enrollment target is 80 participants, below the 1,977-participant average among 7 other Corticobasal Degeneration trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07000851, a study of Corticobasal Degeneration and Corticobasal Syndrome, is actively recruiting participants, sponsored by Jennifer Whitwell.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of this study is to investigate inflammation and white matter damage in corticobasal syndrome and determine whether these processes are related to each other. The investigator's will address our goal by using neuroimaging and blood plasma biomarkers, as well as molecular pathology.
Primary Outcome
Measure whether regional patterns of ER176-PET uptake and white matter microstructure abnormalities using NODDI differ between CBS-4R, CBS-AD, Amn-AD, and HC.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST C-11 ER176 Radiotracer
- DIAGNOSTIC_TEST C-11 PiB
- DIAGNOSTIC_TEST AV1451 Tau
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-06-25 |
| Est. Completion | 2031-03-30 |
What NCT07000851 shows while recruiting
NCT07000851 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,977-participant average among 7 other Corticobasal Degeneration trials with a reported enrollment target (96% lower).
The record links to 4 conditions, with Corticobasal Degeneration appearing as the primary indexed condition, and to 3 interventions - of which C-11 ER176 Radiotracer is the first listed.
NCT07000851 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07000851 about?
NCT07000851 is a clinical study titled "Imaging Studies in Corticobasal Syndrome". The primary goal of this study is to investigate inflammation and white matter damage in corticobasal syndrome and determine whether these processes are related to each other. The investigator's will address our goal by using neuroimaging and blood plasma biomarkers, as well as molecular pathology.
What is the current status of trial NCT07000851?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2025-06-25. Estimated completion is 2031-03-30.
What conditions does trial NCT07000851 study?
This clinical trial studies the following conditions: Corticobasal Degeneration, Corticobasal Syndrome, Corticobasal Syndrome(CBS), Corticobasal Degeneration (CBD).
What interventions are being tested in trial NCT07000851?
The interventions under investigation include: C-11 ER176 Radiotracer (DIAGNOSTIC_TEST), C-11 PiB (DIAGNOSTIC_TEST), AV1451 Tau (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07000851?
This trial is sponsored by Jennifer Whitwell, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07000851 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Corticobasal Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gait Analysis in Neurological Disease
RECRUITING
-
NYSCF Scientific Discovery Biobank
RECRUITING
-
Scrambler Therapy for Corticobasal Syndrome-Associated Pain
RECRUITING · NA
-
The CurePSP Genetics Program
RECRUITING
-
Modifiable Variables in Parkinsonism (MVP)
RECRUITING
-
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI